Devlin J, Page A C, O'Grady J, Portmann B, Karani J, Williams R
Institute of Liver Studies, Kings College School of Medicine and Dentistry, London, UK.
J Hepatol. 1993 Apr;18(1):68-73. doi: 10.1016/s0168-8278(05)80011-x.
We evaluated the contribution of flush and selective hepatic angiography in defining the extent and pattern of major vessel and microvascular arterial lesions and their significance in graft survival. The 50 consecutive patients investigated comprised three clinical groups: Group A (n = 18) were patients with severe graft dysfunction within the first seven days post-transplantation. In this group six of 18 angiograms demonstrated intrahepatic attenuation of the arterial tree suggestive of acute cellular rejection and four of these grafts were lost, compared to a 78% graft survival in the non-arteriopathic group. Group B (n = 16) comprised patients with clinically suspected hepatic arterial thrombosis or stenosis, these diagnoses were confirmed in all patients compared to only 10 positive findings with doppler ultrasonography. Graft survival was only 10% in those patients with artery thrombosis as compared to 100% in those with arterial anastomotic stenoses. Group C patients (n = 16) had histologically confirmed chronic allograft rejection and in ten of them (65%) evidence of arteriopathy was demonstrated despite histological evidence of arteriopathy being present in only 19% of patients. All patients in this group with arteriopathic changes lost their grafts with the exception of one successfully treated with FK506. In two other patients reversibility of chronic rejection was observed, neither of whom had evidence of an arteriopathy.
我们评估了肝动脉造影剂快速注入和选择性肝动脉造影在明确主要血管和微血管动脉病变的范围、模式及其对移植物存活的意义方面的作用。连续接受研究的50例患者分为三个临床组:A组(n = 18)为移植后7天内出现严重移植物功能障碍的患者。在该组中,18例血管造影中有6例显示肝内动脉树变细,提示急性细胞排斥反应,其中4例移植物丢失,而非动脉病变组的移植物存活率为78%。B组(n = 16)包括临床怀疑有肝动脉血栓形成或狭窄的患者,所有患者的这些诊断均得到证实,而多普勒超声检查仅发现10例阳性结果。动脉血栓形成患者的移植物存活率仅为10%,而动脉吻合口狭窄患者的移植物存活率为100%。C组患者(n = 16)经组织学证实有慢性移植物排斥反应,其中10例(65%)有动脉病变证据,尽管组织学证据显示只有19%的患者存在动脉病变。该组所有有动脉病变改变的患者均失去了移植物,但有1例成功接受了FK506治疗。在另外2例患者中观察到慢性排斥反应的可逆性,这2例患者均无动脉病变证据。